A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. Until today this year the stock’s price performance recorded a decrease of -31.50%. However, over the last six months, the performance has been stronger by -16.41%. The price of CCCC decreased -8.94% over the last 30 days. And in the last five days, it has fallen by -4.44%.
C4 Therapeutics Inc’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $11.88 on 03/04/24, and the lowest price during the same period was recorded at $3.61 on 12/18/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of CCCC Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. C4 Therapeutics Inc’s current trading price is -67.42% away from its 52-week high, while its distance from the 52-week low is 7.20%. The stock’s price range over this timeframe has been between $3.61 and $11.88. The shares of the Healthcare sector company recorded a trading volume of approximately 1.65 million for the day, which was comparatively higher than the average daily volume of 1.2 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
C4 Therapeutics Inc (CCCC) has experienced a quarterly decline of -38.18% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 260.40M and boasts a workforce of 145 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 5.48, with a change in price of -2.55. Similarly, C4 Therapeutics Inc recorded 1,182,263 in trading volume during the last 100 days, posting a change of -39.72%.
CCCC’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for CCCC stands at 0.28. Similarly, the long-term debt-to-equity ratio is also 0.25.
CCCC Stock Stochastic Average
The raw stochastic average for C4 Therapeutics Inc over the last 50 days is presently at 7.37%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 17.45%. Further, the company’s Stochastic %K and %D values for the last 20 days were 23.49% and 20.10%, respectively.
